TOPLINE: Tezepelumab reduced the size of nasal polyps and the severity of nasal congestion in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, in a placebo-controlled study. METHODOLOGY: Tezepelumab, a monoclonal antibody that blocks thymic stromal lymphopoietin, is approved as an add-on maintenance treatment for severe asthma. To examine the efficacy and safety of […]
The post Tezepelumab Eases Chronic Rhinosinusitis With Nasal Polyps first appeared on News Health.
Author : News Health
Publish date : 2025-03-10 09:46:00
Copyright for syndicated content belongs to the linked Source.